Correlation of lymphatic vessel density and vascular endothelial growth factor with nodal metastasis in papillary thyroid microcarcinoma

Head and Neck

Volumn 34, Issue 6, 2012, Pages 846-851

  Chung, Man Ki ^a   Kim, Joon Ho ^a   Ko, Young Hyeh ^a   Son, Young Ik ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

lymph node; lymphatic vessel; malignancy; metastasis; thyroid

Indexed keywords

VASCULOTROPIN;

ADULT; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STATISTICAL SIGNIFICANCE; THYROID CARCINOMA; THYROIDECTOMY; UNIVARIATE ANALYSIS;

ADULT; AGED; CARCINOMA, PAPILLARY; COHORT STUDIES; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED; NECK DISSECTION; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROIDECTOMY; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84861328992     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21822     Document Type: Review

References (30)

1. Bramley MD, Harrison BJ,. Papillary microcarcinoma of the thyroid gland. Br J Surg 1996; 83: 1674-1683.
2. Appetecchia M, Scarcello G, Pucci E, Procaccini A,. Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 2002; 21: 159-164.
3. DeGroot LJ, Kaplan EL, McCormick M, Straus FH,. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990; 71: 414-424.
4. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H,. Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg 1996; 131: 187-191.
5. Ito Y, Tomoda C, Uruno T, et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 2006; 30: 91-99.
6. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003; 237: 399-407.
7. Hubert JP Jr, Kiernan PD, Beahrs OH, McConahey WM, Woolner LB,. Occult papillary carcinoma of the thyroid. Arch Surg 1980; 115: 394-398.
8. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
9. Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL,. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid 2000; 10: 349-357.
10. Katoh R, Miyagi E, Kawaoi A, et al. Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms. Hum Pathol 1999; 30: 891-897.
11. Soh EY, Duh QY, Sobhi SA, et al. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign hyroid. J Clin Endocrinol Metab 1997; 82: 3741-3747.
12. Guang-Wu H, Sunagawa M, Jie-En L, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 2000; 110: 2066-2069.
13. Millikan KW, Mall JW, Myers JA, Hollinger EF, Doolas A, Saclarides TJ,. Do angiogenesis and growth factor expression predict prognosis of esophageal cancer? Am Surg 66: 401-406.
14. Mineta H, Miura K, Ogino T, et al. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 2000; 83: 775-781.
15. Hung CJ, Ginzinger DG, Zarnegar R, et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 2003; 88: 3694-3699.
16. Klein M, Vignaud JM, Hennequin V, et al. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 656-658.
17. Yasuoka H, Nakamura Y, Zuo H, et al. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol 2005; 18: 1127-1133.
18. de Araujo-Filho VJ, Alves VA, de Castro IV, et al. Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma. Thyroid 2009; 19: 1233-1237.
19. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002; 62: 1315-1320.
20. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D,. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 2005; 206: 170-177.
21. Straume O, Jackson DG, Akslen LA,. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250-256.
22. Van der Auwera I, Cao Y, Tille JC, et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006; 95: 1611-1625.
23. Chung MK, Min JY, So YK, et al. Correlation between lymphatic vessel density and regional metastasis in squamous cell carcinoma of the tongue. Head Neck 2010; 32: 445-451.
24. Duff SE, Li C, Jeziorska M, et al. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 2003; 89: 426-430.
25. Jussila L, Alitalo K,. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002; 82: 673-700.
26. Longatto-Filho A, Pinheiro C, Ferreira L, et al. Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch 2008; 452: 133-138.
27. Garcia EA, Simoes K, Wakamatsu A, et al. Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions. Endocr Pathol 2010; 21: 101-107.
28. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002; 296: 1883-1886.
29. de la Torre NG, Buley I, Wass JA, Turner HE,. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour. Endocr Relat Cancer 2006; 13: 931-944.
30. Giorgadze TA, Baloch ZW, Pasha T, Zhang PJ, Livolsi VA,. Lymphatic and blood vessel density in the follicular patterned lesions of thyroid. Mod Pathol 2005; 18: 1424-1431.